Elevance Health Inc. closed 31.17% below its 52-week high of $567.26, which the company reached on September 3rd.
A collection of prominent healthcare interests were among the donors to President Donald Trump’s inaugural fund. | The pharma ...
Elevance Health (NYSE:ELV – Get Free Report) was upgraded by research analysts at StockNews.com from a “hold” rating to a ...
We took advantage of Elevance Health's share price weakness in the fourth quarter and added modestly to our investment. Click ...
Health insurance provider Elevance Health (NYSE:EVH) in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was in line with analysts’ consensus ...
Elevance Health, Inc. (NYSE:ELV – Get Free Report) was the recipient of a large increase in short interest in the month of January. As of January 15th, there was short interest totalling 3,630,000 ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...